Circulating miR-126-3p is a mechanistic biomarker for knee osteoarthritis

Document Type

Article

Publication Date

2-27-2025

Publication Title

Nat Commun

Abstract

Osteoarthritis is a major contributor to pain and disability worldwide, yet there are currently no validated soluble biomarkers or disease-modifying treatments. Given that microRNAs are promising mechanistic biomarkers that can be therapeutically targeted, in this study, we aimed to identify and prioritize reproducible circulating microRNAs associated with radiographic knee osteoarthritis. Across four independent cohorts, we find circulating miR-126-3p is elevated in knee osteoarthritis versus controls. Across six primary human knee osteoarthritis tissues, miR-126-3p is highest in subchondral bone, fat pad and synovium, and lowest in cartilage. Following both intravenous and intra-articular miR-126-3p mimic treatment in a surgical mouse model of knee osteoarthritis, we show reduced disease severity in males. In human knee osteoarthritis biospecimens, miR-126-3p mimic treatment reduces genes and markers associated with angiogenesis, as well as genes linked to osteogenesis, adipogenesis, and synovitis-processes secondary to angiogenesis. Our findings indicate that miR-126-3p is elevated in knee osteoarthritis and mitigates disease severity, supporting its potential as a biomarker and therapeutic target.

Medical Subject Headings

MicroRNAs; Osteoarthritis, Knee; Humans; Biomarkers; Male; Animals; Mice; Female; Middle Aged; Aged; Disease Models, Animal; Mice, Inbred C57BL

PubMed ID

40016267

Volume

16

Issue

1

First Page

2021

Last Page

2021

Find It @ Sladen

Share

COinS